← HomeGlossary
Key terms, defined plainly.
- Family Office
- A privately held firm managing a single family’s capital and investments. Hillman Ventures was founded in 1995.
- Frontier Biotech
- Early-stage biotechnology in inflammation, damaged tissue, and tumor-based cancers.
- 351(a) BLA
- A Biologics License Application under the Public Health Service Act, the full approval pathway for a biologic.
- RMAT
- Regenerative Medicine Advanced Therapy, an FDA designation that can expedite eligible therapies.
- 510(k)
- A premarket submission showing a device is substantially equivalent to a marketed device.
- Pre-IND
- An early FDA meeting to align on a development plan before an Investigational New Drug application.
- Strategic Exit
- The sale or transfer of an operating company to a strategic or financial acquirer.
- Diligence
- Independent review of a company or thesis before investment.